This MedLibrary.org supplementary page on Haemonetics is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
| Type | Public (NYSE: HAE) |
|---|---|
| Founded | 1971 |
| Headquarters | Braintree, Massachusetts, USA |
| Key people | Brad Nutter, President and CEO Peter Allen, President, Donor Division |
| Industry | Computer software Healthcare Blood banking |
| Employees | 1,800 |
| Website | www.haemonetics.com |
Haemonetics (NYSE: HAE) is a global provider of blood and plasma supplies and services. Founded in Braintree, Massachusetts in the 1970s, the company has expanded and has many offices located in 16 countries.
They started out producing the containers and bags required for blood collection. From there they have branched off to making the whole plasma collection station including the machine, supplies and software for plasma collection. They have recently acquired several companies in an effort to expand their services. These acquisitions include Canadian based Fifth Dimension (5D) Information Systems in order to gain entry into the blood and plasma software industry. Further acquisitions include Chicago based Arryx in July 2006,1 Information Data Management Inc. in January 2007,2 and Infonale in July 2007.3
Haemonetics continued to increase its products and services with the planned acquisition of Haemoscope announced in October 2007.4
On August 21, 2007, 5D and IDM were officially merged into a new subsidiary called Haemonetics Software Solutions.5 The employees at both Edmonton (5D) and Rosemont (IDM) continue to work from their respective offices.
Haemonetics products can be considered as belonging to two broad categories:
- donor products (marketed to the blood donation industry, these include products that automate the blood donation process, automate the processing of blood, support pathogen inactivation and bacterial detection of blood, and test blood hematocrit),
- and patient products (products are marketed to the surgical suite for blood loss management for patients. The products include surgical blood salvage (or "autotransfusion") devices, surgical field blood suction systems, and blood and patient warming systems).
The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas.
Notes
References
- Arryx Acquisition (18-July-2006) Retrieved on April 20, 2007
- IDM acquisition (30-January-2007) Retrieved on April 20, 2007
- Infonale acquisition (10-July-2007) Retrieved on August 21, 2007
- Creation of Haemonetics Software Solutions (24-August-2007) Retrieved on January 20, 2008
- Haemoscope acquisition (1-November-2007) Retrieved on January 20, 2008
External links
This United States corporation or company article is a stub. You can help Wikipedia by expanding it.
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
Wikipedia content modification information:
- This page was last modified on 23 October 2008, at 15:48.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Haemonetics".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.